US STOCKS-Tekmira Pharma, AbbVie among premarket actives

NEW YORK, Sept 23 (Reuters) - U.S.-listed shares of Tekmira Pharmaceuticals were climbing on Tuesday, up 8.9 percent at $25.70 as one of the most actively trades Nasdaq stocks as its Ebola drug will be one of several to be tested in West Africa in a bid to win fast-track trials.